These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 34001997)

  • 1. Diffusion-weighted and dynamic contrast-enhanced magnetic resonance imaging after radiation therapy for bone metastases in patients with hepatocellular carcinoma.
    Lee JH; Yoo GS; Yoon YC; Park HC; Kim HS
    Sci Rep; 2021 May; 11(1):10459. PubMed ID: 34001997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of diffusion-weighted magnetic resonance imaging in the treatment response evaluation of hepatocellular carcinoma patients treated with radiation therapy.
    Yu JI; Park HC; Lim DH; Choi Y; Jung SH; Paik SW; Kim SH; Jeong WK; Kim YK
    Int J Radiat Oncol Biol Phys; 2014 Jul; 89(4):814-21. PubMed ID: 24969795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance-guided focused ultrasound for the treatment of painful bone metastases: role of apparent diffusion coefficient (ADC) and dynamic contrast enhanced (DCE) MRI in the assessment of clinical outcome.
    Anzidei M; Napoli A; Sacconi B; Boni F; Noce V; Di Martino M; Saba L; Catalano C
    Radiol Med; 2016 Dec; 121(12):905-915. PubMed ID: 27567615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffusion and perfusion MRI prediction of progression-free survival in patients with hepatocellular carcinoma treated with concurrent chemoradiotherapy.
    Kim KA; Park MS; Ji HJ; Park JY; Han KH; Kim MJ; Kim KW
    J Magn Reson Imaging; 2014 Feb; 39(2):286-92. PubMed ID: 24302545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histogram analysis parameters identify multiple associations between DWI and DCE MRI in head and neck squamous cell carcinoma.
    Meyer HJ; Leifels L; Schob S; Garnov N; Surov A
    Magn Reson Imaging; 2018 Jan; 45():72-77. PubMed ID: 28963049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular carcinoma: short-term reproducibility of apparent diffusion coefficient and intravoxel incoherent motion parameters at 3.0T.
    Kakite S; Dyvorne H; Besa C; Cooper N; Facciuto M; Donnerhack C; Taouli B
    J Magn Reson Imaging; 2015 Jan; 41(1):149-56. PubMed ID: 24415565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusion-Related MRI Parameters for Assessing Early Treatment Response of Liver Metastases to Cytotoxic Therapy in Colorectal Cancer.
    Kim JH; Joo I; Kim TY; Han SW; Kim YJ; Lee JM; Han JK
    AJR Am J Roentgenol; 2016 Sep; 207(3):W26-32. PubMed ID: 27303858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of bone metastases from prostate cancer and benign red marrow depositions of the pelvic bone with multiparametric MRI.
    Park S; Park JG; Jun S; Kim H; Kim TS; Kang H
    Magn Reson Imaging; 2020 Nov; 73():118-124. PubMed ID: 32860869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging in the activity staging of terminal ileum Crohn's disease.
    Wu YC; Xiao ZB; Lin XH; Zheng XY; Cao DR; Zhang ZS
    World J Gastroenterol; 2020 Oct; 26(39):6057-6073. PubMed ID: 33132655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravoxel incoherent motion diffusion-weighted MR imaging of hepatocellular carcinoma: correlation with enhancement degree and histologic grade.
    Woo S; Lee JM; Yoon JH; Joo I; Han JK; Choi BI
    Radiology; 2014 Mar; 270(3):758-67. PubMed ID: 24475811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of diffusion-weighted, intravoxel incoherent motion, and dynamic contrast-enhanced MR imaging in the assessment of response to radiotherapy of lytic bone metastases from breast cancer.
    Gaeta M; Benedetto C; Minutoli F; D'Angelo T; Amato E; Mazziotti S; Racchiusa S; Mormina E; Blandino A; Pergolizzi S
    Acad Radiol; 2014 Oct; 21(10):1286-93. PubMed ID: 25088834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravoxel incoherent motion diffusion-weighted magnetic resonance imaging for predicting histological grade of hepatocellular carcinoma: Comparison with conventional diffusion-weighted imaging.
    Zhu SC; Liu YH; Wei Y; Li LL; Dou SW; Sun TY; Shi DP
    World J Gastroenterol; 2018 Feb; 24(8):929-940. PubMed ID: 29491686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiparametric approach with diffusion-weighted imaging and dynamic contrast-enhanced MRI: a comparison study for differentiating between benign and malignant bone lesions in adults.
    Oh E; Yoon YC; Kim JH; Kim K
    Clin Radiol; 2017 Jul; 72(7):552-559. PubMed ID: 28325514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Change in diffusion weighted MRI during liver cancer radiotherapy: preliminary observations.
    Eccles CL; Haider EA; Haider MA; Fung S; Lockwood G; Dawson LA
    Acta Oncol; 2009; 48(7):1034-43. PubMed ID: 19634060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Volumetric Apparent Diffusion Coefficient Histogram Analysis in Differentiating Intrahepatic Mass-Forming Cholangiocarcinoma From Hepatocellular Carcinoma.
    Zou X; Luo Y; Li Z; Hu Y; Li H; Tang H; Shen Y; Hu D; Kamel IR
    J Magn Reson Imaging; 2019 Apr; 49(4):975-983. PubMed ID: 30277628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
    Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
    J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical relevance of the apparent diffusion coefficient value of metastatic bone tumours on diffusion-weighted MRI images: differences according to the types of primary tumour, the affected bones, and clinical factors.
    Cha MJ; Yoon YC
    Clin Radiol; 2015 Oct; 70(10):1116-21. PubMed ID: 26145186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immediate post-doxorubicin drug-eluting beads chemoembolization Mr Apparent diffusion coefficient quantification predicts response in unresectable hepatocellular carcinoma: A pilot study.
    Kokabi N; Camacho JC; Xing M; Edalat F; Mittal PK; Kim HS
    J Magn Reson Imaging; 2015 Oct; 42(4):981-9. PubMed ID: 25683022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative dynamic contrast-enhanced and diffusion-weighted MRI for differentiation between nasopharyngeal carcinoma and lymphoma at the primary site.
    Yu XP; Hou J; Li FP; Xiang W; Lu Q; Hu Y; Wang H
    Dentomaxillofac Radiol; 2016; 45(3):20150317. PubMed ID: 26846711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiologic-pathologic analysis of contrast-enhanced and diffusion-weighted MR imaging in patients with HCC after TACE: diagnostic accuracy of 3D quantitative image analysis.
    Chapiro J; Wood LD; Lin M; Duran R; Cornish T; Lesage D; Charu V; Schernthaner R; Wang Z; Tacher V; Savic LJ; Kamel IR; Geschwind JF
    Radiology; 2014 Dec; 273(3):746-58. PubMed ID: 25028783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.